[Application of impulse complex modulated electromagnetic fields in management of patients with diabetic polyneuropathy].
← Research streamIn 121 patients with diabetic polyneuropathy assessed before and after treatment, application of impulse complex modulated electromagnetic fields (100 Hz and 10 Hz) was reported to promote regression of basic clinical symptoms and improvement in several elect…
Study snapshot
Abstract
One hundred and twenty-one patients with diabetic polyneuropathy (DP) underwent a clinical and electroneuromyographic investigation before and after treatment with impulse complex modulated electromagnetic fields (ICM EMF) of varying frequency (100 and 10 Hz). Based on TSS and NIS LL scale tests, a correlation between the progression and occurrence of the basic subjective and objective signs of the disease and a DP stage was revealed. The alterations of segmental and peripheral neuromotor system manifesting in reduction of muscular bioelectrical activity, impulse conduction velocities in efferent fibers of peripheral nerves and maximal M-response amplitude were found to be related to DP stage and diabetes mellitus duration. A decrease of H-reflex amplitude and Hmax/Mmax ratio measured in crural muscles proved to be the earliest and most significant electroneuromyographic DP trait. ICM EMF application promotes a regression of DP basic clinical symptoms, an improvement of conduction function of peripheral nerves and 1a afferents state as well as a reflex excitability of functionally different spinal motoneurons. Therapeutic efficacy of a 10 Hz ICM EMF, particularly for DP primary stages and diabetes mellitus up to 10-year duration, was proved.
AI evidence extraction
Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.
Main findings
In 121 patients with diabetic polyneuropathy assessed before and after treatment, application of impulse complex modulated electromagnetic fields (100 Hz and 10 Hz) was reported to promote regression of basic clinical symptoms and improvement in several electroneuromyographic measures (including conduction function of peripheral nerves and reflex-related measures). The abstract states therapeutic efficacy was shown for 10 Hz exposure, particularly in early-stage diabetic polyneuropathy and diabetes duration up to 10 years.
Outcomes measured
- Clinical symptoms of diabetic polyneuropathy
- TSS score
- NIS LL score
- Electroneuromyographic measures (muscular bioelectrical activity, impulse conduction velocities in efferent fibers of peripheral nerves, maximal M-response amplitude)
- H-reflex amplitude
- Hmax/Mmax ratio
- Conduction function of peripheral nerves
- State of Ia afferents
- Reflex excitability of spinal motoneurons
Limitations
- No control or comparison group described in the abstract
- Randomization/blinding not described
- Exposure parameters beyond frequency (e.g., intensity, duration, dosing) not reported
- Follow-up duration not reported
View raw extracted JSON
{
"study_type": "other",
"exposure": {
"band": null,
"source": "therapeutic electromagnetic field device (impulse complex modulated EMF)",
"frequency_mhz": null,
"sar_wkg": null,
"duration": null
},
"population": "Patients with diabetic polyneuropathy",
"sample_size": 121,
"outcomes": [
"Clinical symptoms of diabetic polyneuropathy",
"TSS score",
"NIS LL score",
"Electroneuromyographic measures (muscular bioelectrical activity, impulse conduction velocities in efferent fibers of peripheral nerves, maximal M-response amplitude)",
"H-reflex amplitude",
"Hmax/Mmax ratio",
"Conduction function of peripheral nerves",
"State of Ia afferents",
"Reflex excitability of spinal motoneurons"
],
"main_findings": "In 121 patients with diabetic polyneuropathy assessed before and after treatment, application of impulse complex modulated electromagnetic fields (100 Hz and 10 Hz) was reported to promote regression of basic clinical symptoms and improvement in several electroneuromyographic measures (including conduction function of peripheral nerves and reflex-related measures). The abstract states therapeutic efficacy was shown for 10 Hz exposure, particularly in early-stage diabetic polyneuropathy and diabetes duration up to 10 years.",
"effect_direction": "benefit",
"limitations": [
"No control or comparison group described in the abstract",
"Randomization/blinding not described",
"Exposure parameters beyond frequency (e.g., intensity, duration, dosing) not reported",
"Follow-up duration not reported"
],
"evidence_strength": "insufficient",
"confidence": 0.66,
"peer_reviewed_likely": "yes",
"keywords": [
"diabetic polyneuropathy",
"impulse complex modulated electromagnetic fields",
"ICM EMF",
"10 Hz",
"100 Hz",
"electroneuromyography",
"H-reflex",
"nerve conduction",
"TSS",
"NIS LL"
],
"suggested_hubs": []
}AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.
Identifiers and source
DOI: Not supplied
PubMed: 12520773
Related papers
- Evaluation of the efficacy of pulsed electromagnetic field in the management of patients with diabetic polyneuropathy. 2009
- Effect of Short-time Exposure of Local Extremely Low-Frequency Magnetic Fields on Sleepiness in Male Rats 2022
- Healthy disorders by WLAN-exposure 2022
- Exposure to 10 Hz Pulsed Magnetic Fields Do Not Induce Cellular Senescence in Human Fetal Lung Fibroblasts 2021
- Effect of Short-time Exposure of Local Extremely Low-Frequency Magnetic Fields on Sleepiness in Male Rats 2022
- Evaluation of frequency magnetic field, static field, and Temozolomide on viability, free radical production and gene expression (p53) in the human glioblastoma cell line (A172) 2020